Back
Avenue Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
20
ATXI
Avenue Therapeutics
Last Price:
$1.74
Seasonality Move:
9.82%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.
Avenue Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.76 | Sell |
| 20-day SMA: | 1.86 | Sell |
| 50-day SMA: | 2.02 | Sell |
| 200-day SMA: | 4.18 | Sell |
| 8-day EMA: | 1.78 | Sell |
| 20-day EMA: | 1.85 | Sell |
| 50-day EMA: | 2.03 | Sell |
| 200-day EMA: | 10.37 | Sell |
Avenue Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 39.36 | Sell |
| Chaikin Money Flow: | -15000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 2.01) | Sell |
| Bollinger Bands (100): | (1.92 - 2.64) | Sell |
Avenue Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avenue Therapeutics Stock
Is Avenue Therapeutics Stock a Buy?
-
Avenue Therapeutics share price is 1.72 while ATXI 8-day simple moving average is 1.76, which is a Sell signal.
-
The stock price of ATXI is 1.72 while Avenue Therapeutics 20-day SMA is 1.86, which makes it a Sell.
-
Avenue Therapeutics 50-day simple moving average is 2.02 while ATXI share price is 1.72, making it a Sell technically.
-
ATXI stock price is 1.72 and Avenue Therapeutics 200-day simple moving average is 4.18, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
20
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy or a Sell?
-
Avenue Therapeutics stock is rated a SellThe current Avenue Therapeutics [ATXI] share price is $1.72. The Score for ATXI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics Stock Info
Market Cap:
3.5M
Price in USD:
1.72
Share Volume:
19.6K
Avenue Therapeutics 52-Week Range
52-Week High:
26.47
52-Week Low:
1.60
Sell
20
Avenue Therapeutics (ATXI)
is a Sell
Avenue Therapeutics Share Price Forecast
-
What is the Avenue Therapeutics stock price today?The Avenue Therapeutics stock price is 1.72 USD today.
-
Will ATXI stock go up or go down?Avenue Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avenue Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics is overvalued.
Is Avenue Therapeutics Stock a Buy?
-
Avenue Therapeutics share price is 1.72 while ATXI 8-day exponential moving average is 1.78, which is a Sell signal.
-
The stock price of ATXI is 1.72 while Avenue Therapeutics 20-day EMA is 1.85, which makes it a Sell.
-
Avenue Therapeutics 50-day exponential moving average is 2.03 while ATXI share price is 1.72, making it a Sell technically.
-
ATXI stock price is 1.72 and Avenue Therapeutics 200-day simple moving average is 10.37, creating a Sell signal.
Technical Analysis of Avenue Therapeutics
Should I short Avenue Therapeutics stock?
-
ATXI Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Avenue Therapeutics is a Sell
-
Avenue Therapeutics Relative Strength Index (RSI) is 39.36, which suggest Avenue Therapeutics is oversold
-
The Bollinger Bands (25) for Avenue Therapeutics is (1.77 - 2.01), which suggest Avenue Therapeutics is a Sell
-
The Bollinger Bands (100) for Avenue Therapeutics is (1.92 - 2.64), which suggest Avenue Therapeutics is a Sell
* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.